Abstract
Introduction. Severe mental disorders represent a risk factor for violent episodes. Aggressiveness and violence can be expressed verbally or behaviorally, and aggression events may occur in different clinical settings during any stage of mental disorder’s course. We sought to define a set of communication techniques and guidelines in order to improve prevention and reduce aggressive and violent episodes’ damage risk in mental healthcare. De-escalation is conceived as a process comprising the ability to gradually resolve a potentially violent situation. It consists of different steps of communication, both verbal and nonverbal, aimed to defuse a potentially violent situation. Neurobiological correlates. De-escalation acts on potential aggressive manifestations which are influenced by common neurophysiological underpinnings: these neurobiological correlates involve the HPA axis (hypothalamic-pituitary-adrenal axis) which is strongly associated with stress reaction, leading to a profound cortisol release and activation of neurotransmitter pathways and hormonal systems. Techniques and methods. Structured procedures involving different communication techniques, based on specific clinical needs, are required. De-escalation is intended to interrupt emotional activation, to establish a relationship with the agitated individual, and to provide the opportunity to resettle a functional emotional management. Conclusions. Dysfunctional conducts and aggressive behaviors may arise from mental health issues. Mental health operators should develop communication techniques and de-escalation abilities aimed to effectively manage critical situations and prevent critical interactions or physical aggression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Witt K, van Dorn R, Fazel S. Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies [published correction appears in PLoS One. 2013;8(9). doi:10.1371/annotation/f4abfc20-5a38-4dec-aa46-7d28018bbe38]. PLoS One. 2013;8(2):e55942. https://doi.org/10.1371/journal.pone.0055942.
Iozzino L, Ferrari C, Large M, Nielssen O, de Girolamo G. Prevalence and risk factors of violence by psychiatric acute inpatients: a systematic review and meta-analysis. PLoS One. 2015;10(6):e0128536. https://doi.org/10.1371/journal.pone.0128536.
Ziaei M, Massoudifar A, Rajabpour-Sanati A, Pourbagher-Shahri AM, Abdolrazaghnejad A. Management of violence and aggression in emergency environment; a narrative review of 200 related articles. Adv J Emerg Med. 2018;3(1):e7. https://doi.org/10.22114/AJEM.v0i0.117.
Clements PT, DeRanieri JT, Clark K, Manno MS, Kuhn DW. Workplace violence and corporate policy for health care settings. Nurs Econ. 2005;23(3):119–24, 07.
Gerberich SG, Church TR, McGovern PM, Hansen H, Nachreiner NM, Geisser MS, et al. Risk factors for work-related assaults on nurses. Epidemiology. 2005;16(5):704–9.
Van Dorn R, Volavka J, Johnson N. Mental disorder and violence: is there a relationship beyond substance use? Soc Psychiatry Psychiatr Epidemiol. 2012;47(3):487–503. https://doi.org/10.1007/s00127-011-0356-x.
Whittington R, Richter D. From the individual to the interpersonal: environment and interaction in the escalation of violence in mental health settings. In: Richter D, Whittington R, editors. Violence in mental health settings: causes, consequences, management. New York, NY: Springer Science + Business Media; 2006. p. 47–65. https://doi.org/10.1007/978-0-387-33965-8_3.
Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2009;66(2):152–61. https://doi.org/10.1001/archgenpsychiatry.2008.537.
National Institute for Clinical Excellence (NICE). Violence and aggression: short-term management in mental health, health and community settings. London: NICE; 2015. https://www.nice.org.uk/guidance/ng10. Accessed June 2019.
Allen JJ, Anderson CA, Bushman BJ. The general aggression model. Curr Opin Psychol. 2018;19:75–80. https://doi.org/10.1016/j.copsyc.2017.03.034.
Lukens TW, Wolf SJ, Edlow JA, et al. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med. 2006;47:79–99.
Andrade C. Rapid tranquillisation in emergency psychiatric settings. BMJ. 2007;335(7625):835–6. https://doi.org/10.1136/bmj.39359.614387.80.
Amdur E. Grace under fire: skills for calming and de-escalating aggressive and mentally ill individuals. 2nd ed. Shoreline, WA: Edgework Books; 2011.
Kaplan SG, Wheeler EG. Survival skills for working with potentially violent clients. Social Casework. 1983;64(6):339–46.
Nelson RJ, Trainor BC. Neural mechanisms of aggression. Nat Rev Neurosci. 2007;8(7):536–46. https://doi.org/10.1038/nrn2174.
Wrangham RW. Two types of aggression in human evolution. Proc Natl Acad Sci. 2018;115(2):245–53. https://doi.org/10.1073/pnas.1713611115.
Keynejad RC, Frodl T, Kanaan R, Pariante C, Reuber M, Nicholson TR. Stress and functional neurological disorders: mechanistic insights. J Neurol Neurosurg Psychiatry. 2019;90(7):813–21. https://doi.org/10.1136/jnnp-2018-318297.
Veenema AH, Torner L, Blume A, Beiderbeck DI, Neumann ID. Low inborn anxiety correlates with high intermale aggression: link to ACTH response and neuronal activation of the hypothalamic paraventricular nucleus. Horm Behav. 2007;51(1):11–9. https://doi.org/10.1016/j.yhbeh.2006.07.004.
Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267(9):1244–52. https://doi.org/10.1001/jama.1992.03480090092034.
van Honk J, Peper JS, Schutter DJ. Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biol Psychiatry. 2005;58(3):218–25. https://doi.org/10.1016/j.biopsych.2005.04.003.
Haller J, Mikics E, Halasz J, Toth M. Mechanisms differentiating normal from abnormal aggression: glucocorticoids and serotonin. Eur J Pharmacol. 2005;526(1–3):89–100. https://doi.org/10.1016/j.ejphar.2005.09.064.
Reardon AF, Hein CL, Wolf EJ, Prince LB, Ryabchenko K, Miller MW. Intermittent explosive disorder: associations with PTSD and other Axis I disorders in a US military veteran sample. J Anxiety Disord. 2014;28(5):488–94. https://doi.org/10.1016/j.janxdis.2014.05.001.
Hökfelt T, Bartfai T, Bloom F. Neuropeptides: opportunities for drug discovery. Lancet Neurol. 2003;2(8):463–72. https://doi.org/10.1016/S1474-4422(03)00482-4.
Lin D, Boyle MP, Dollar P, Lee H, Lein E, Perona P, et al. Functional identification of an aggression locus in the mouse hypothalamus. Nature. 2011;470(7333):221. https://doi.org/10.1038/nature09736.
Summers CH, Winberg S. Interactions between the neural regulation of stress and aggression. J Exp Biol. 2006;209(23):4581–9. https://doi.org/10.1242/jeb.02565.
Vaeroy H, Schneider F, Fetissov SO. Neurobiology of aggressive behavior-role of autoantibodies reactive with stress-related peptide hormones. Front Psych. 2019;10:872. https://doi.org/10.3389/fpsyt.2019.00872.
Fetissov SO, Hallman J, Nilsson I, Lefvert AK, Oreland L, Hökfelt T. Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol Psychiatry. 2006;60(8):799–802. https://doi.org/10.1016/j.biopsych.2006.03.081.
Takagi K, Legrand R, Asakawa A, Amitani H, François M, Tennoune N, et al. Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun. 2013;4(2685):1–11. https://doi.org/10.1038/ncomms3685.
Dutt M, Jialal I. Physiology, adrenal gland. StatPearls. Bethesda, MD: StatPearls Publishing; 2019.
Allen MJ, Sharma S. StatPearls. In: Physiology, adrenocorticotropic hormone (ACTH). Bethesda, MD: StatPearls Publishing; 2019.
Vaeroy H, Adori C, Legrand R, Lucas N, Breton J, Cottard C, et al. Autoantibodies reactive to adrenocorticotropic hormone can alter cortisol secretion in both aggressive and nonaggressive humans. Proc Natl Acad Sci U S A. 2018;115(28):E6576–e6584. https://doi.org/10.1073/pnas.1720008115.
Brain PF, Evans AE. Acute influences of some ACTH-related peptides of fighting and adrenocortical activity in male laboratory mice. Pharmacol Biochem Behav. 1977;7(5):425–33. https://doi.org/10.1016/0091-3057(77)90210-6.
Nowell N, Thody A, Woodley R. α-Melanocyte stimulating hormone and aggressive behavior in the male mouse. Physiol Behav. 1980;24(1):5–9. https://doi.org/10.1016/0031-9384(80)90006-2.
Campbell A. Oxytocin and human social behavior. Pers Soc Psychol Rev. 2010;14(3):281–95. https://doi.org/10.1177/1088868310363594.
Stoop R. Neuromodulation by oxytocin and vasopressin. Neuron. 2012;76(1):142–59. https://doi.org/10.1016/j.neuron.2012.09.025.
Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25(49):11489–93. https://doi.org/10.1523/JNEUROSCI.3984-05.2005.
Huber D, Veinante P, Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science. 2005;308(5719):245–8. https://doi.org/10.1126/science.1105636.
Neumann ID. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog Brain Res. 2002;139:147–62. https://doi.org/10.1016/S0079-6123(02)39014-9.
Parker KJ, Buckmaster CL, Schatzberg AF, Lyons DM. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology. 2005;30(9):924–9. https://doi.org/10.1016/j.psyneuen.2005.04.002.
Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003;54(12):1389–98. https://doi.org/10.1016/S0006-3223(03)00465-7.
de Goeij DC, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJ. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology. 1991;53(2):150–9. https://doi.org/10.1159/000125712.
Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 1983;305(5932):325–7. https://doi.org/10.1038/305325a0.
Scott LV, Dinan TG. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci. 1998;62(22):1985–98. https://doi.org/10.1016/S0024-3205(98)00027-7.
Larkin GL, Claassen CA, Emond JA, et al. Trends in U.S. emergency department visits for mental health conditions, 1992 to 2001. Psychiatr Serv. 2005;56:671–7.
Nordstrom K, Allen MH. Managing the acutely agitated and psychotic patient. CNS Spectr. 2007;12:5–11.
Nicolò G, Pompili E, Silvestrini C, Lagrotteria B, Laglia C. Gestione dell’aggressività cap. XIV. In: Manuale di psichiatria territoriale. Pisa: Pacini Editore Medicina; 2015.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Accinni, T., Papadogiannis, G., Orso, L. (2021). De-escalation Techniques in Various Settings. In: Biondi, M., Pasquini, M., Tarsitani, L. (eds) Empathy, Normalization and De-escalation. Springer, Cham. https://doi.org/10.1007/978-3-030-65106-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-65106-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65105-3
Online ISBN: 978-3-030-65106-0
eBook Packages: MedicineMedicine (R0)